Australian vaccine set for overseas test

The effectiveness of a University of Queensland vaccine for coronavirus is about to be tested in a biosecurity facility in the Netherlands.

The vaccine will be used on live coronavirus for the first time to determine how effectively it induces protection against infection.

UQ's vaccine program co-leader Dr Keith Chappell said the trial will establish a critical package of data ahead of human clinical trials later this year. Clinical studies will be conducted by Viroclinics Xplore which offers a myriad of preclinical tests including toxicology of drugs, antibodies, and antivirals targeting viral infectious diseases.

 

UQ created COVID-19 in its laboratory and then set about designing a vaccine to combat the virus.

The vaccine locks the "spike" protein into a shape which allows the immune system to be able to recognise and neutralise it.

UQ's Professor Trent Munro said beginning a large multi-arm study at Viroclinics Xplore was critical, before human testing, because it would establish a more comprehensive understanding of how the vaccine performs.

Originally published as UQ coronavirus vaccine set for overseas test


REVEALED: Burnett streets most likely to be theft targets

Premium Content REVEALED: Burnett streets most likely to be theft targets

Data from Queensland Police has revealed the streets in the Burnett most likely to...

North Burnett street art captures national attention

Premium Content North Burnett street art captures national attention

Two North Burnett towns have captured the nation’s eye, taking home national...

Paramedics rush to car rollover near Kingaroy

Premium Content Paramedics rush to car rollover near Kingaroy

Emergency services rushed to the scene of a single vehicle rollover just outside of...